- Low liver function test ties to higher death risk after heart attack
- Helps doctors spot high-risk NSTEMI patients sooner
- Not yet in use—still being tested in real clinics
This simple liver test may help predict which heart attack patients face the highest risk after leaving the hospital.
A 68-year-old leaves the hospital after a mild heart attack. He feels okay. His heart tests looked stable. But three months later, he’s gone.
Why?
New research points to a clue most doctors don’t check: a routine liver test called the ALBI score.
Heart attacks aren’t all the same. NSTEMI is a common type—less severe than others, but still dangerous.
It affects hundreds of thousands every year. Patients often go home feeling fine. But some die within months, and doctors struggle to know who’s at risk.
Current tools use heart scans, cholesterol, and blood pressure. But they miss warning signs outside the heart.
What if the answer lies in the liver?
The Hidden Link
For years, doctors treated liver and heart health as separate. A high ALBI score means poor liver function. It’s been used in liver disease and cancer.
But here’s the twist: the liver plays a quiet role in inflammation and healing—key factors after a heart attack.
This study asked: Can a liver test predict heart patients’ survival?
Think of your body like a city. The heart is the power plant. The liver? It’s the cleanup crew.
When the city suffers a blackout (a heart attack), the cleanup crew helps restore order. If the crew is weak or overwhelmed, recovery stalls.
The ALBI score measures how strong that crew is—using just two common blood markers: albumin (a protein) and bilirubin (a waste product).
Low albumin + high bilirubin = struggling liver = harder recovery.
It’s like judging a mechanic’s toolkit before a big repair job.
Researchers looked back at 982 NSTEMI patients. All had their ALBI score calculated from routine blood tests after hospital admission. They were followed for an average of two years after discharge.
No extra tests. No new machines. Just data already collected.
Patients with the highest (worst) ALBI scores were far more likely to die after going home.
In the worst group, death risk was 5 times higher—even after adjusting for age, kidney function, and heart damage.
That’s like flipping a coin and getting heads five times in a row—by chance, it almost never happens.
The ALBI score also outperformed other common tools in predicting death risk. It was more accurate than the widely used MELD score and even matched some heart-specific risk models.
This doesn’t mean this treatment is available yet.
But there’s a catch.
The ALBI score didn’t add much for patients who already had clear signs of severe illness. Its real power? Spotting hidden risk in patients who seem stable.
Imagine passing a car that looks fine after an accident. No dents. Windows intact. But the engine is damaged. ALBI might be the diagnostic tool that sees under the hood.
While not part of this study, liver-heart links are gaining attention. Experts say chronic inflammation and poor metabolism—both tied to liver health—can worsen heart outcomes.
This adds to growing evidence that whole-body health matters after a heart event. Not just the heart.
One expert called it “a shift from organ-specific thinking to patient-centered care.”
If you or a loved one has had a heart attack, you may already get albumin and bilirubin tests. They’re part of standard blood work.
But doctors don’t yet use the ALBI score to guide care for heart patients. It’s not on the radar for most cardiologists.
Should you ask for it? Not yet. But this research could change that.
Talk to your doctor about overall risk—not just heart numbers, but liver, kidneys, and nutrition.
Health isn’t just one organ. It’s all connected.
The Limits
This was a retrospective study—meaning researchers looked back at old data. They didn’t control who got tested or how. All patients came from one hospital in China, so results might differ elsewhere.
Also, while the link is strong, it doesn’t prove the ALBI score causes higher risk. It shows association—like noticing umbrellas when it rains, but not causing the storm.
And no lifestyle factors—like diet or alcohol—were included, which affect both liver and heart health.
What Scientists Didn’t Expect
They thought ALBI might help—but not this much. It held up even after adjusting for age, diabetes, kidney function, and heart damage.
Even more surprising: the relationship wasn’t linear. Once the ALBI score crossed a certain point, risk shot up fast—like a switch flipping.
Restricted cubic spline analysis showed a sharp rise in death risk beyond a threshold. That means small changes in liver function could signal big shifts in survival odds.
Larger, forward-looking studies are needed. Researchers must confirm these results in diverse groups and see if acting on ALBI scores improves outcomes. For now, it’s a promising tool—simple, cheap, and already available. But it’s not standard care. The journey from data to doctor’s orders takes time. And every step must be proven safe and fair for all patients.
